Loading...
XCNQ
GLOW
, Last price  
CAD
Name

Glow Lifetech Corp

Chart & performance

D1W1MN
XCNQ:GLOW chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
35.26%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
2m
+145.60%
0005,0066,2200000000000043,931836,1932,053,668
Net income
-618k
L-76.75%
9,491-321,000-198,000-318,000-243,000-344,000-279,000-1,597,000-1,435,000453,416-449,000-187,000-56,135-153,000-11,314,377-2,243,000-1,589,000-2,657,000-617,861
CFO
-15k
L-98.89%
16,631-18,651-3,181,061-1,295,340-417,265-1,349,672-15,026

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced technology, which facilitates the optimal delivery of nutrients for both nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to help users and patients store, track, manage, and consume cannabis products effectively. Glow Lifetech possesses exclusive rights throughout North America for the production, sale, and distribution of a specific micellization technology, applicable to cannabis and hemp-derived ingredients, curcumin, Vitamin K, and iron. A key aspect of their operations involves the advanced processing of ingredients, converting certain vitamins, nutraceuticals, and cannabis extracts into micellized forms. This process significantly boosts the bioavailability of fat-soluble compounds, ensuring near 100% absorption into the body and enhancing their compatibility with water. The company, founded in 2018, is headquartered in Toronto, Canada.

Key people

Ashley Makuch
President, Chief Financial Officer, Corporate Secretary, Director · since 2016
Peter Evans
Independent Director · since 2008
IPO date
Mar 15, 2021
Employees
Domiciled in
CA
Incorporated in
CA
Headquarters & legal address
65 International Blvd, Suite 103 Etobicoke
TORONTO, ON M9W 6L9
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT